Citation Impact
Citing Papers
Breaking Up Prolonged Sitting Reduces Postprandial Glucose and Insulin Responses
2012
Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors
2014
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
1997 Standout
Use and Abuse of HOMA Modeling
2004 Standout
Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies
2003
Complementing Insulin Therapy to Achieve Glycemic Control
2013
Severe Hypoglycemia and Risks of Vascular Events and Death
2010 Standout
High Glucose‐induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling
2011
Wearable biosensors for healthcare monitoring
2019 Standout
Vitamin E in Humans: Demand and Delivery
1996
Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status
1991
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The β-Thalassemias
1999 Standout
Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
1990 Standout
Toward Understanding Tight Glycemic Control in the ICU
2009
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Pathogenesis of Selective Insulin Resistance in Isolated Hepatocytes
2015
Coronary heart disease: seven dietary factors
1991 Standout
Calorie Restriction Improves Cardiovascular Risk Factors via Reduction of Mitochondrial Reactive Oxygen Species in Type II Diabetic Rats
2006
Hormonal Regulation of Hepatic Glucose Production in Health and Disease
2011
Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited
2008
Obesity, Weight Gain, and the Risk of Kidney Stones
2005 Standout
Vascular disease and diabetes: is hypoglycaemia an aggravating factor?
2008
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study
2006
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Biology of Incretins: GLP-1 and GIP
2007 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
The influence of antioxidant nutrients on platelet function in healthy volunteers
1997
High–glycemic index carbohydrate increases nuclear factor-κB activation in mononuclear cells of young, lean healthy subjects
2008
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
2012
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Inflammatory Bowel Disease
2002 Standout
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
2008
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Management of Hyperglycemia in Acute Ischemic Stroke
2011
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
2015
Type 2 diabetes
2017 Standout
Good stress, bad stress and oxidative stress: Insights from anticipatory cortisol reactivity
2013
Type 1 diabetes
2013 Standout
Polycystic Ovary Syndrome
2005 Standout
Redox clocks: Time to rethink redox interventions
2017
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studies
2009
Insulin Sensitivity and Its Measurement: Structural Commonalities among the Methods1
2000
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Effect of Eicosapentaenoic and Docosahexaenoic Acids on Blood Pressure in Hypertension
1990
Glucotypes reveal new patterns of glucose dysregulation
2018
Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review
2017 Standout
Skeletal Muscle Fatty Acid Handling in Insulin Resistant Men
2011
Efficacy and tolerability of vildagliptin in drug‐naïve patients with type 2 diabetes and mild hyperglycaemia*
2008
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
2009
Vitamin E and heart disease:
2000
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
2021
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Supplementation with mixed tocopherols increases serum and blood cell γ-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes
2006
Antioxidants and Platelets
1989
Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease
1996
Adipose Tissue as an Endocrine Organ
2004 Standout
Pre-eclampsia
2015 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
The Incretin Mimetic Exenatide as a Monotherapy in Patients with Type 2 Diabetes
2007
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Improved Cardio-Respiratory Fitness Correlates with Changes in the Number and Size of Small Dense LDL: Randomized Controlled Trial with Exercise Training and Dietary Instruction
2009
Wearable Contact Lens Biosensors for Continuous Glucose Monitoring Using Smartphones
2018
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy
2012
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
2002
A Real-World Approach to Insulin Therapy in Primary Care Practice
2005
Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms
1990
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
2017
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
The Pathobiology of Diabetic Complications
2005 Standout
Genetic Variation in the Peroxisome Proliferator–Activated Receptor-γ2 Gene (Pro12Ala) Affects Metabolic Responses to Weight Loss and Subsequent Weight Regain
2001
The Effect of α-Tocopherol Supplementation on LDL Oxidation
1995
Oxidative Stress and Diabetic Complications
2010 Standout
Deep learning with long short-term memory networks for financial market predictions
2017 Standout
Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes
2005
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
Insulin Glulisine Provides Improved Glycemic Control in Patients With Type 2 Diabetes
2004
Inflammatory Mechanisms in Obesity
2011 Standout
The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes
2020
Glucose and leptin induce apoptosis in human β‐ cells and impair glucose‐stimulated insulin secretion through activation of c‐Jun N‐terminal kinases
2008
Mechanisms of Diabetic Complications
2013 Standout
Evidence for Insulin Involvement in Arginine- and Glucose-Induced Hypercalciuria in the Rat
1983
Part 8: Post–Cardiac Arrest Care
2015 Standout
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction
2013
Electrochemical Glucose Sensors and Their Applications in Diabetes Management
2008 Standout
The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches
1995
Homeostasis Model Assessment Is a Reliable Indicator of Insulin Resistance During Follow-up of Patients With Type 2 Diabetes
2001
Initiating Insulin Therapy in Type 2 Diabetes
2005
Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults
2015 Standout
Homeostasis Model Assessment of Insulin Resistance in Relation to the Incidence of Cardiovascular Disease
2002
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2006
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction
2001
A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes
2009
Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System
2007
Continuous Glucose Monitoring Systems: A Review
2013
Works of C Colette being referenced
The Loss of Postprandial Glycemic Control Precedes Stepwise Deterioration of Fasting With Worsening Diabetes
2007
Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy
2009
Insulin and atherosclerosis: How are they related?
2013
An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives
2005
Acute Glucose Fluctuations and Chronic Sustained Hyperglycemia as Risk Factors for Cardiovascular Diseases in Patients with Type 2 Diabetes
2007
Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state
1999
Relationship between insulin sensitivity, obesity, body fat distribution and β-endorphinaemia in obese women
1998
Insulin alters nuclear factor-κB and peroxisome proliferator-activated receptor-γ protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells
2005
Platelet function in type I diabetes: effects of supplementation with large doses of vitamin E
1988
Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom?
2007
Basal insulin analogs: From pathophysiology to therapy. What we see, know, and try to comprehend?
2013
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
Enteral absorption in man of eicosapentaenoic acid in different chemical forms
1987
Effects of dietary fiber on postprandial glycemic profiles in diabetic patients submitted to continuous programmed insulin infusion
1984
Magnitude of the Dawn Phenomenon and Its Impact on the Overall Glucose Exposure in Type 2 Diabetes
2013
Intestinal and renal handling of calcium in human diabetes mellitus: influence of acute oral glucose loading and diabetic control
1978
[The effects of heparin in underdevelopment of the fetus due to maternal vascular conditions (author's transl)].
1979
Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients
2003
Plasma β-Thromboglobulin Response to Insulin-induced Hypoglycemia in Type I Diabetic Patients
1984
Evidence for 25‐hydroxyvitamin D deficiency as a factor contributing to osteopenia in diabetic patients with idiopathic haemochromatosis
1980
Morning Hyperglycemic Excursions
2002